Procter & Gamble Health 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Milind Thatte

최고 경영자

₹32.2m

총 보상

CEO 급여 비율	100.0%
CEO 임기	6.6yrs
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	5.4yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Milind Thatte 의 보수는 Procter & Gamble Health 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Sep 30 2024	n/a	n/a	₹2b
Jun 30 2024	₹32m	₹32m	₹2b
Mar 31 2024	n/a	n/a	₹2b
Dec 31 2023	n/a	n/a	₹2b
Sep 30 2023	n/a	n/a	₹2b
Jun 30 2023	₹25m	₹25m	₹2b
Mar 31 2023	n/a	n/a	₹2b
Dec 31 2022	n/a	n/a	₹2b
Sep 30 2022	n/a	n/a	₹2b
Jun 30 2022	₹39m	₹39m	₹2b
Mar 31 2022	n/a	n/a	₹2b
Dec 31 2021	n/a	n/a	₹1b
Sep 30 2021	n/a	n/a	₹2b
Jun 30 2021	₹32m	₹32m	₹2b
Mar 31 2021	n/a	n/a	₹2b
Dec 31 2020	n/a	n/a	₹2b
Sep 30 2020	n/a	n/a	₹2b
Jun 30 2020	₹17m	₹26m	₹2b
Mar 31 2020	n/a	n/a	₹2b
Dec 31 2019	n/a	n/a	₹2b
Sep 30 2019	n/a	n/a	₹1b
Jun 30 2019	n/a	n/a	₹1b
Mar 31 2019	n/a	n/a	₹1b
Dec 31 2018	₹20m	₹13m	₹1b

보상 대 시장: Milind 의 총 보상 ($USD 381.72K )은 Indian 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 355.26K ).

보상과 수익: Milind 의 보상은 작년에 20% 이상 증가한 반면 회사 수익은 20% 이상 감소했습니다.

CEO

Milind Thatte (55 yo)

6.6yrs

테뉴어

₹32,234,000

보상

Mr. Milind Vasant Thatte, M.Pharm.Sci., M.B.A., has been Managing Director and Executive Director of Procter & Gamble Health Limited (formerly known as Merck Limited) since April 1, 2018. Mr. Thatte had a...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Milind Thatte	MD & Executive Director	6.6yrs	₹32.23m	데이터 없음
Lokesh Chandak	CFO, Finance Head & Executive Director	1.6yrs	₹24.94m	데이터 없음
Suresh Talwar	Non-Executive Independent Chairman of the Board	40.8yrs	₹2.33m	0.036% ₹ 30.1m
Subramanian Madhavan	Non-Executive Independent Director	3yrs	₹2.20m	데이터 없음
Rani Jadhav	Non-Executive Independent Director	9.8yrs	₹2.18m	데이터 없음
Aalok Agrawal	Non-Executive Director	5.4yrs	데이터 없음	데이터 없음
Seema Sambasivan	Non-Executive Director	1.6yrs	데이터 없음	데이터 없음

5.4yrs

평균 재임 기간

61.5yo

평균 연령

경험이 풍부한 이사회: 500126 의 이사회는 경험(평균 재직 기간 5.4 년)으로 간주됩니다.

Procter & Gamble Health 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Procter & Gamble Health Limited, Annual General Meeting, Dec 05, 2024

Less than half of directors are independent

Procter & Gamble Health Limited, Annual General Meeting, Nov 30, 2023

Procter & Gamble Health Limited Announces Change in Senior Management Personnel

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Upcoming dividend of ₹60.00 per share

First quarter 2025 earnings released: EPS: ₹49.60 (vs ₹39.50 in 1Q 2024)

Procter & Gamble Health Limited to Report Q1, 2025 Results on Nov 04, 2024

Final dividend of ₹60.00 announced

Procter & Gamble Health Limited, Annual General Meeting, Dec 05, 2024

Full year 2024 earnings released: EPS: ₹121 (vs ₹138 in FY 2023)

Procter & Gamble Health Limited to Report Q4, 2024 Results on Aug 21, 2024

Third quarter 2024 earnings released: EPS: ₹28.00 (vs ₹35.70 in 3Q 2023)

Procter & Gamble Health Limited to Report Q3, 2024 Results on May 02, 2024

Second quarter 2024 earnings released: EPS: ₹43.40 (vs ₹46.30 in 2Q 2023)

Procter & Gamble Health Limited Declares Special Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024

Less than half of directors are independent

Procter & Gamble Health Limited, Annual General Meeting, Nov 30, 2023

Procter & Gamble Health Limited to Report Q1, 2024 Results on Nov 03, 2023

Procter & Gamble Health Limited Recommends Final Dividend,Payable Between November 28, 2023 to December 18, 2023

Full year 2023 earnings released: EPS: ₹138 (vs ₹116 in FY 2022)

Procter & Gamble Health Limited Announces Change in Senior Management Personnel

Procter & Gamble Health Limited to Report Fiscal Year 2023 Results on Aug 23, 2023

Third quarter 2023 earnings released: EPS: ₹35.70 (vs ₹30.80 in 3Q 2022)

Less than half of directors are independent

Less than half of directors are independent

Procter & Gamble Health Limited Recommends an Interim Dividend for the Financial Year 2022-23, Payable on or Before March 05, 2023

Second quarter 2023 earnings released: EPS: ₹46.30 (vs ₹27.00 in 2Q 2022)

Less than half of directors are independent

First quarter 2023 earnings released: EPS: ₹38.30 (vs ₹33.40 in 1Q 2022)

Upcoming dividend of ₹11.50 per share

Procter & Gamble Health Limited to Report Q3, 2022 Results on Nov 09, 2022

Procter & Gamble Health Limited, Annual General Meeting, Nov 23, 2022

Full year 2022 earnings released: EPS: ₹116 (vs ₹107 in FY 2021)

Procter & Gamble Health Limited Recommends Final Dividend for the Financial Year Ended June 30, 2022, Payable Between November 28, 2022 to December 18, 2022

Procter & Gamble Health Limited to Report Fiscal Year 2022 Results on Aug 29, 2022

Procter & Gamble Health Limited Recommends Interim Dividend for the Financial Year 2021-22, payable on or before May 31, 2022

Third quarter 2022 earnings released: EPS: ₹30.80 (vs ₹9.50 in 3Q 2021)

Less than half of directors are independent

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of ₹130 per share

Full year 2021 earnings released: EPS ₹107 (vs ₹99.87 in FY 2020)

Non-Executive Director Sujay Wasan has left the company

Full year 2021 earnings released: EPS ₹107 (vs ₹99.87 in FY 2020)

Procter & Gamble Health Limited Recommends One-Time Special Dividend for the Financial Year Ended June 30, 2021

Company Secretary & Compliance Officer Preeti Bishnoi has left the company

New 90-day low: ₹6,562

Second quarter 2021 earnings released: EPS ₹40.90 (vs ₹23.02 in 2Q 2020)

New 90-day high: ₹7,315

New 90-day high: ₹7,107

New 90-day high: ₹7,030

First quarter 2021 earnings released: EPS ₹35.70

New 90-day high: ₹5,682

Full year earnings released - EPS ₹99.98

New 90-day high - ₹5,251

Procter & Gamble Health Limited to Report Q2, 2020 Results on Sep 15, 2020

New 90-day high - ₹4,879

New 90-day high - ₹4,402

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령